Transplant centers reject viable kidneys to protect their CMS performance ratings, so patients die waiting for a 'perfect' organ that never comes

Every year in the United States, roughly 9,000 recovered kidneys are declined and discarded — an 83% increase in kidney nonuse over the last five years. This is not because these kidneys are unusable. Studies show that 62% of kidneys discarded in the U.S. would have been successfully transplanted in France. The organs sit in coolers, get offered to center after center, and each center declines because the kidney comes from an older donor, has minor anatomical defects, or carries a marginally elevated risk profile. So what? Because transplant centers are graded by CMS on post-transplant survival rates using absolute thresholds (e.g., minimum 95% one-year survival). Any center that transplants a 'risky' kidney into a 'risky' patient and that patient dies has their survival numbers dragged down. If a center gets flagged as underperforming, it faces regulatory scrutiny, potential loss of Medicare certification, and reputational damage. The rational response is to decline marginal organs and delist high-risk patients. In the five years after CMS adopted these standards, more than 4,300 transplant candidates were removed from waiting lists — an 86% increase from the prior five-year period. So what? The patients who are delisted or passed over are disproportionately older, sicker, and from marginalized communities. They return to dialysis, which costs Medicare roughly $90,000 per patient per year and has a five-year survival rate of about 35%, compared to roughly 85% for transplant recipients. Every 'risk-averse' organ decline is a quiet death sentence for someone who would have had better odds with an imperfect kidney than with no kidney at all. This problem persists because the incentive structure is fundamentally misaligned. CMS measures transplant center success by what happens to patients who get transplants, not by what happens to patients who don't. There is no penalty for declining a viable organ. There is no metric tracking how many patients a center let die on the waitlist while refusing kidneys. Until the performance system measures lives saved rather than post-transplant survival rates among cherry-picked patients, centers will keep throwing away kidneys to protect their ratings.